Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NETI
3326
DELISTED
Eneti Inc.
NETI
| $182K | ﹤0.01% |
15,000
-86,209
| -85% | -$841K |
|
3327
USCB Financial Holdings
USCB
$416M
| $180K | ﹤0.01% |
17,600
+1,600
| +10% | +$15.7K |
|
|
FSFG
3328
DELISTED
First Savings Financial Group
FSFG
| $178K | ﹤0.01% |
13,400
+400
| +3% | +$5.42K |
|
|
CTO
3329
CTO Realty Growth
CTO
$826M
| $177K | ﹤0.01% |
+10,301
| New | +$170K |
|
3330
Spyre Therapeutics
SYRE
$9B
| $177K | ﹤0.01% |
15,720
+8,476
| +117% | +$40.2K |
|
3331
Janux Therapeutics
JANX
$996M
| $176K | ﹤0.01% |
+14,800
| New | +$198K |
|
3332
Aegon
AEG
$13.8B
| $168K | ﹤0.01% |
33,167
-266,429
| -89% | -$1.22M |
|
3333
XBiotech
XBIT
$73.2M
| $168K | ﹤0.01% |
28,335
-24,160
| -46% | -$109K |
|
3334
AEye
LIDR
$61.4M
| $167K | ﹤0.01% |
30,803
+17,336
| +129% | +$107K |
|
3335
TeraWulf
WULF
$8.46B
| $167K | ﹤0.01% |
+95,200
| New | +$145K |
|
3336
Scienjoy Holding
SJ
$36.9M
| $164K | ﹤0.01% |
59,700
+5,400
| +10% | +$21.1K |
|
|
OPTN
3337
DELISTED
OptiNose
OPTN
| $163K | ﹤0.01% |
8,820
-4,107
| -32% | -$97.1K |
|
|
ISPO
3338
DELISTED
Inspirato
ISPO
| $162K | ﹤0.01% |
8,275
+6,065
| +274% | +$109K |
|
|
SHCO
3339
DELISTED
Soho House & Co
SHCO
| $162K | ﹤0.01% |
29,800
-26,500
| -47% | -$167K |
|
|
TRVN
3340
DELISTED
Trevena, Inc.
TRVN
| $160K | ﹤0.01% |
7,286
+4,465
| +158% | +$109K |
|
|
ESPR
3341
DELISTED
Esperion Therapeutics
ESPR
| $159K | ﹤0.01% |
+114,300
| New | +$160K |
|
3342
NexGen Energy
NXE
$6.94B
| $159K | ﹤0.01% |
33,800
-183,600
| -84% | -$745K |
|
3343
SIFCO Industries
SIF
$123M
| $159K | ﹤0.01% |
64,434
+3,700
| +6% | +$9.99K |
|
3344
Alpha Teknova
TKNO
$404M
| $159K | ﹤0.01% |
59,700
-22,000
| -27% | -$59K |
|
|
FNCB
3345
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $159K | ﹤0.01% |
26,598
+5,898
| +28% | +$35.4K |
|
|
RBT
3346
DELISTED
Rubicon Technologies, Inc.
RBT
| $159K | ﹤0.01% |
53,600
+46,387
| +643% | +$172K |
|
3347
ESS Tech
GWH
$19.7M
| $158K | ﹤0.01% |
7,160
-2,920
| -29% | -$52.8K |
|
|
SOGP
3348
Sound Group
SOGP
$47M
| $158K | ﹤0.01% |
17,360
+200
| +1% | +$1.58K |
|
3349
Beasley Broadcasting Group
BBGI
$46.2M
| $157K | ﹤0.01% |
7,716
+500
| +7% | +$9.61K |
|
|
BLRX
3350
BioLineRX
BLRX
$11.7M
| $157K | ﹤0.01% |
2,468
-184
| -7% | -$10.2K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.